Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2005American Journal of Therapeutics

Pharmacokinetics and Pharmacodynamics of Febuxostat, a New Non-purine Selective Inhibitor of Xanthine Oxidase in Subjects with Renal Impairment

View Full Paper
Ask AI
Bookmark
Share

Authors

MMMichael D. MayerImperial College LondonRKReza KhosravanExelixis (United States)LVLaurent VernilletBC Cancer Agency

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mayer et al. (2005) studied this question.

synapsesocial.com/papers/69d7f0455c3030ff03d1879bhttps://doi.org/10.1097/00045391-200501000-00005
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched one closely related paper. Consider it for comparative context:

  1. 1The Management of Gout1996 · 516 citations